COMMUNIQUÉS West-GlobeNewswire

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

17/10/2024 - 15:41

-- LUMRYZ is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy— -- Granted Orphan Drug Exclusivity in [...]

WellRithms Selected for BenefitsPRO’s 2024 Luminaries Awards

17/10/2024 - 16:00

PORTLAND, Ore., Oct. 17, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, has been named to BenefitsPRO Luminaries Class of 2024 in the Rising Star category, one of only two recipients [...]

New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women

17/10/2024 - 16:00

NEWARK, Del., Oct. 17, 2024 (GLOBE NEWSWIRE) -- A new study published last week in the “Journal of Clinical Medicine” has revealed promising results for sacrospinous ligament (SSL) fixation using the EnPlace ® device, a [...]

Rapafusyn Pharmaceuticals to Present In Vivo Data on ENT1 Inhibitor for Acute Kidney Injury at the American Society for Nephrology (ASN Kidney Week 2024)

17/10/2024 - 16:24

BALTIMORE, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a leader in the field of non-degrading molecular glues, is pleased to announce the upcoming presentation of preclinical in vivo data from its [...]

Dr. Wenming Chen to Receive Asian Myeloma Network Distinguished Service Award at the 8th AMN Summit in Seoul

17/10/2024 - 16:41

International Myeloma Foundation (IMF) to hold AMN Awards Ceremony at the 8th AMN Summit in Seoul, South Korea on Saturday, October 19 SEOUL, South Korea, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The International Myeloma [...]

Emergex Announces Company Name Change to “Gylden Pharma Limited” Reflecting Company’s Commitment to Advanced Core Technologies and Expanded Product Pipeline

17/10/2024 - 17:00

ABINGDON, United Kingdom, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited, a clinical-stage biotechnology company that is addressing major global infectious diseases through the development of [...]

VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024.

17/10/2024 - 17:45

CHIFFRES CLÉS Chiffre d’affaires à fin septembre 2024 1 042,1 M€ Croissance à taux de change et périmètre constants 1 +8,6% dont animaux de compagnie +11,9% animaux d’élevage +3,2% Croissance à taux de change constants [...]

Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

17/10/2024 - 17:45

KEY FIGURES Revenue at the end of September €1 042.1M Growth at constant exchange rates and scope 1 +8.6% including companion animals +11.9% farm animals +3.2% Growth at constant exchange rates 2 +14.0% Overall change + [...]

EssilorLuxottica: Chiffre d’affaires T3/9M 2024 - Solide croissance du chiffre d'affaires à +4 %

17/10/2024 - 18:00

Chiffre d’affaires T3/9M 2024 Solide croissance du chiffre d'affaires à +4 % Hausse de 4,0 % du chiffre d’affaires à taux de change constants 1 au troisième trimestre, +4,9 % depuis le début de l'année Croissance du [...]

EssilorLuxottica: Q3/9M 2024 Revenue - Revenue keeping a solid 4% growth

17/10/2024 - 18:00

Q3/9M 2024 Revenue Revenue keeping a solid 4% growth Group’s revenue up 4.0% at constant exchange rates 1 in Q3, +4.9% year to date Revenue positive in both segments in all the regions in Q3 North America up low-single [...]

OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré

17/10/2024 - 18:00

OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré Nantes, France, le 17 octobre 2024 [...]

OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index

17/10/2024 - 18:00

NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , today announced it will be presenting its novel OSE-CYTOMASK Cis-Demasking 1 cytokine technology in oral [...]

Enlitic Acquires Laitek, Revolutionizing Medical Imaging Data Management

17/10/2024 - 18:09

Enlitic raises AU$22.5M to fund acquisition and ongoing operations Highlights Enlitic’s acquisition of LAITEK advances Enlitic’s strategic roadmap and represents an inflection point for the Company Enlitic has raised AU [...]

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

17/10/2024 - 19:29

COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE D'AUTORISATION CONDITIONNELLE DE MISE SUR LE MARCHÉ DU MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Paris, 17 octobre 2024, 19h30 AB [...]

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

17/10/2024 - 19:29

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024, 7.30pm CET AB Science SA ( [...]

Wyatt Surgery Center Selects Nextech Platform for Revenue Cycle Management

17/10/2024 - 19:30

Billing Services Drives Significant Increase in Collections and Cash Flow TAMPA, Fla., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nextech, market leader of comprehensive technology solutions for specialty physician practices, [...]

Les présentations de Theratechnologies lors de l’IDWeek mettent en évidence l’incidence de l’excès de graisse viscérale abdominale sur le risque de maladie cardiovasculaire chez les personnes vivant avec le VIH

17/10/2024 - 20:00

Selon les données, la tésamoréline pourrait réduire le risque de maladie cardiovasculaire en diminuant l’excès de graisse viscérale abdominale MONTRÉAL, 17 oct. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« [...]

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV

17/10/2024 - 20:00

Data Show Tesamorelin May Reduce CVD Risk by Reducing EVAF MONTREAL, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company [...]

SpyGlass Pharma Presents Promising 18-month Data of its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with Glaucoma

17/10/2024 - 20:35

Mean intraocular pressure (IOP) was reduced by 43.7% from baseline at month 18 All patients remained off topical IOP-lowering medications and achieved >20% IOP reduction All eyes achieved Visual Acuity (BCDVA) of 20/ [...]